5thPort’s innovative approach to patient engagement in radiation oncology using AI patient education videos, gained international recognition last week at the International Congress on Innovative Approaches in Head and Neck Oncology (ICHNO 2026) in Seville, Spain.
5thPort is proud to announce that research co-authored by its team has been selected for a prestigious podium presentation at the American Head and Neck Society (AHNS) 12th Annual International Conference on Head and Neck Cancer. The conference will take place July 18–22, 2026, at the Menino Convention and Exhibition Center in Boston, Massachusetts.
A new study co-authored by ChristianaCare's Radiation Oncology department and 5thPort has been published in the Red Journal – the official journal of the American Society for Radiation Oncology (ASTRO) and one of the most respected publications in cancer research and clinical innovation. The study, titled "A Pilot Study Incorporating AI-Based Avatar Digital Engagements for Patients in a Community Radiation Oncology Practice," evaluated the use of pre-consultation digital patient engagements, including multiple-choice teach-back quizzes, within a community radiation oncology setting.
5thPort™ is excited to exhibit at ASTRO 2024's Annual Meeting, scheduled between September 29 - October 2, 2024.
5thPort™ is proud to announce its partnership with Rocky Mountain Clinical Research (RMCR), a premier Clinical Research institution based in Idaho. After careful evaluation of various solutions in the market, RMCR selected 5thPort™'s digital patient engagement and eConsenting platform for its advanced functionalities and easily configurable/prescriptive patient education capabilities.
Dr. Robert Berube will be speaking at HIMSS Global Health Conference & Exhibition about the advantages of cloud-based digital patient engagement and e-Consent technology. In the presentation, Dr. Berube will highlight 5thPort's e-Consent capabilities and how it helped the clinic realize the value in the way of administrative efficiencies, the reduced risk of uninformed patients and the documented improvements in patient experiences.
With 30+ years of work experience and 13+ years of expertise in Clinical Research, Suresh Kumar joins 5thPort as Senior Vice President, Sales. Suresh advocates for patient experience, and helping hospitals, academic medical centers, research institutions and contact research organizations (CROs) overcome their patient engagement and e-Consent challenges.
Learn how 5thPort, a new Cloud-based digital patient engagement and e-Consent solution, is built to help contract research organizations (CROs) address four primary challenges in both site-based and decentralized clinical trials (DCTs).
Discover how 5thPort can help sites, sponsors, CROs, and solution providers save trial costs and mitigate risk with a new Cloud-based digital patient engagement and e-Consent solution.
5thPort™, the best-in-class cloud-based patient engagement and eConsent solution, announces significant enhancements in its latest release for clinical trials and healthcare providers.
